INMD InMode MD: Likuiditas cepet

InMode Ltd. (INMD) revenues are based on the sale of advanced aesthetic systems, where Morpheus8 radiofrequency devices have become the key profit generator. This price chart with the 7.25 indicator confirms the market dynamics. However, geopolitical tensions and sanctions are hindering equipment exports, reducing the customer base. Meanwhile, production capacities are operating stably, undergoing scheduled electronics modernization while maintaining high assembly quality.

This ratio assesses the issuer's ability to instantaneously settle short-term obligations using exclusively cash and accounts receivable, excluding inventory. By analyzing the quick ratio, an investor can gauge the financial stability of InMode Ltd. (INMD), where the high margins of its patented rejuvenation systems allow for the accumulation of significant liquid reserves, minimizing default risks during expansion within the aesthetic medicine market.